<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "https://jats.nlm.nih.gov/publishing/1.3/JATS-journalpublishing1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" article-type="research-article" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">ijcmcr</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Clinical &amp; Medical Case Reports</journal-title>
      </journal-title-group>
      <issn publication-format="electronic">2834-250X</issn>
      <publisher>
        <publisher-name>International Journal of Clinical &amp; Medical Case Reports</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories>
      <title-group>
        <article-title>Investigation Of MiRNA-MiRNA Network And Critical Targets in The Progression Of Alzheimer’s Disease</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sarabi</surname>
            <given-names>Pedram Asadi</given-names>
          </name>
          <aff>Faculty of Sciences and Advanced Technologies in Biology, University of Science and Culture, Tehran, Iran; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Techno...</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bereimipour</surname>
            <given-names>Ahmad</given-names>
          </name>
          <aff>Faculty of Sciences and Advanced Technologies in Biology, University of Science and Culture, Tehran, Iran; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Techno...</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Taleahmad</surname>
            <given-names>Sara</given-names>
          </name>
          <aff>Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, P.O. Box 19395-4644, Tehran, Iran</aff>
        </contrib>
      </contrib-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>29</day>
        <month>02</month>
        <year>2024</year>
      </pub-date>
      <volume>5</volume>
      <issue>7</issue>
      <history>
        <date date-type="received"><day>06</day><month>02</month><year>2024</year></date>
        <date date-type="accepted"><day>24</day><month>02</month><year>2024</year></date>
      </history>
      <permissions>
        <copyright-statement>© 2024 The Author(s). Published by International Journal of Clinical &amp; Medical Case Reports.</copyright-statement>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0).</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Alzheimer’s disease (AD) is a neurologic ailment that causes the brain to atrophy and brain cells to die over time. AD is the most prevalent form of dementia, which is a gradual decrease in cognitive, behavioral, and social abilities that impairs a person’s capacity to operate independently. In this study, bioinformatics analysis was conducted to look into possible miRNA-mRNA couples implicated in the etiology of AD to find DEmiRNAs and genes unique to Alzheimer’s disease. Two suitable datasets (GSE18309 and GSE16759) from peripheral blood mononuclear cells (PBMCs) and the parietal lobe of AD patients were selected from the GEO database. Then, we used the online enrichment databases to evaluate signaling pathways, gene ontology, protein networks, and hub miRNAs. We Also used Cytoscape to design the interactive networks. Our results showed that, hsa-mir-765, hsa-mir-575, hsa-mir-425 3p, hsa-mir-198, hsa-mir-602, hsa-mir-601, hsa-mir-454-3p, hsa-mir-558, hsa-mir-448, and hsa-mir-542-5p were prominent role in exacerbate of AD. It was discovered that an abundance of miRNA-mRNA interactions implicated in synaptic transmission, aberrant protein degradation, and apoptosis. Additionally, EGF, ESR1, DLG4, CTTN, WASL, FN1, JUN, CDKN2A, and PRKCA gene expression in Alzheimer’s disease patients was considerably reduced in PBMCs. This study adds to our knowledge of the hsa-mir-765, hsa-mir-575, hsa-mir-425 3p, and hsa-mir-198 that may underlie Alzheimer’s disease and identifies novel diagnostic and therapeutic targets for the disease.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Alzheimer’s Disease</kwd>
        <kwd>Bioinformatics Analysis</kwd>
        <kwd>Mirnas</kwd>
        <kwd>Mrnas</kwd>
      </kwd-group>
    </article-meta>
  </front>
</article>
